• Product NameRecombinant Human KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4
• Brief DescriptionRecombinant Protein
• Immunogen DescriptionFusion protein corresponding to a region derived from 22-213 amino acids of human killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3/1/4/ short cytoplasmic tail, 4
• Target Namekiller cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3/1/4/ short cytoplasmic tail, 4
• Alternative Names    p58; NKAT; GL183; NKAT2; CD158b; NKAT2A; NKAT2B; CD158B2; KIR-K7b; KIR-K7c; KIRCL23; KIR-023GB/NKAT; NKAT1; p58.1; CD158A; KIR221; KIR-K64/ G9P; CD158D; KIR103; KIR103AS/ KKA3; KIR1D; NKAT8; CD158I; KIR412
• Accession No. Swissprot:P43628/P43626/Q99706/P43632
  Gene Accession:BC032422/ ADQ31987/ NP_002246/ NP_036446
• UniprotP43628
• Gene ID3804;
• Storage -20~-80˚C, pH 7.6 PBS

Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several "framework" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain.

Note: For in vitro research use only, not for diagnostic or therapeutic use. This product is not a medical device.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting